medline.ch Dermatologie Tumoren

conid:1756
-kaloNeDinamik-------------------------------------------jo
-session-------------------------------------------Array
(
    [ID_S] => IP: 100.24.115.215; DATE: 2022/05/18/ 12:10:50
    [tip] => 2
    [contentType] => db
    [ses_userid] => 2
    [thisMode] => 
    [level_0] => 2
    [level_1] => 2
    [level_2] => 8
    [level_3] => 0
    [level_4] => 0
    [level] => 2
    [nodetype] => 2
    [node_family_id] => 0
    [monitor] => content
    [id_contentit_from_php_file] => 1756
    [uniqueid] => 20220518121050100241152158564
    [lang] => Lng1
    [contentId] => 1756
    [browser] => IE
    [clas_css] => 0
    [level_p] => 2
    [lng] => Lng1
    [nodetype_ci] => -1
    [usr] => 0
    [vazhdopunen] => po
    [search_for] => ("skin neoplasms"[majr] OR melanoma[ti] OR melanoma[majr] OR basalioma[ti] OR "carcinoma, basal cell"[majr] OR "carcinoma, squamous cell"[majr] OR spinalioma[ti]) AND ("practice guideline" OR systematic[sb] OR "clinical trials"[mesh] OR "meta analysis"[pt] OR "epidemiologic studies"[mesh] OR randomi* OR "meta analysis" OR "evidence based" OR placebo* OR "single blind" OR "double blind" OR "control group" OR "triple blind" OR study[ti] OR studies[ti] OR trial[ti] OR trials[ti] OR consensus OR placebo OR review[pt] OR "sensitivity and specificity"[MeSH Terms] OR diagnos*[Ti] OR diagnosis[MeSH:noexp] OR diagnostic *[MeSH:noexp] OR diagnosis,differential[MeSH:noexp] OR diagnosis[Subheading:noexp] OR accuracy[Title/Abstract] OR "predictive value"[Title/Abstract]) AND (english[language] OR german[language] OR french[language] OR italian[language] OR spanish[language])NOT veterinary[subheading] 
)

medline.ch

En | De

Impressum | Feedback

Sie sind hier: Dermatologie » Tumoren

18. Mai 2022

Photosensitive Erkrankungen

Kardiovaskuläre Erkrankungen

Muskuloskelettale Erkrankungen

Schrift:

Seite 1 von 6063


	Artikel 1 - 20 / 121244

	ASO Visual Abstract: An Evidence-Based Staging System for Mucosal Melanoma: a Proposal. Ann Surg Oncol Cui C, Lian B, Zhang X, Wu D, Li K, Si L, Yang Y, Tian H, Zhou L, Chi Z, Sheng X, Kong Y, Mao L, Wang X, Bai X, Yan X, Li S, Dai J, Tang B, Wei X, Gershenwald JE, Balch CM, Guo J. PMID: 35579763 [PubMed - as supplied by publisher]
	Female melanoma and estrogen receptors expression: an immunohistochemical pilot study. Melanoma Res Dika E, Lambertini M, Lauriola M, Veronesi G, Ricci C, Tartari F, Tassone D, Campione E, Scarfì F. PMID: 35579670 [PubMed - as supplied by publisher]
	Factors Related to Delayed Diagnosis of Cutaneous Melanoma in the Brazilian Public Health System. J Cancer Educ Paula Bhering Nogueira A, Drummond-Lage AP, Drumond Ribeiro GP, Ferreira Leite E, Henrique Xavier M, Julius Alves Wainstein A. PMID: 35578128 [PubMed - as supplied by publisher]
	The roles of TGF-Î² and VEGF pathways in the suppression of antitumor immunity in melanoma and other solid tumors. Pharmacol Ther Bu MT, Chandrasekhar P, Ding L, Hugo W. PMID: 35577211 [PubMed - as supplied by publisher]
	Loss of 'Epidermal Melanin Unit' Integrity in Human Skin During Melanoma-Genesis. Front Oncol Casalou C, Moreiras H, Mayatra JM, Fabre A, Tobin DJ. PMID: 35574390 [PubMed]
	Assessment of the Novel, Practical, and Prognosis-Relevant TNM Staging System for Stage I-III Cutaneous Melanoma. Front Oncol Hu D, Liu Z, Chen S, Huang Y, Zeng W, Wei W, Zhang C, Zhou L, Chen D, Wu Y, Guo L. PMID: 35574383 [PubMed]
	Sun Protection Behavior in Danish Outdoor Workers Following a Multicomponent Intervention. Front Public Health Jakobsen MM, Mortensen OS, Grandahl K. PMID: 35570895 [PubMed - indexed for MEDLINE]
	European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022. Eur J Cancer Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, Bastholt L, Bataille V, Del Marmol V, Dréno B, Fargnoli MC, Forsea AM, Grob JJ, Höller C, Kaufmann R, Kelleners-Smeets N, Lallas A, Lebbé C, Lytvynenko B, Malvehy J, Moreno-Ramirez D, Nathan P, Pellacani G, Saiag P, Stratigos AJ, Van Akkooi ACJ, Vieira R, Zalaudek I, Lorigan P, European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC).. PMID: 35570085 [PubMed - as supplied by publisher]
	Single agent Talimogene Laherparepvec for stage IIIB-IVM1c melanoma patients: a systematic review and meta-analysis. Crit Rev Oncol Hematol Stahlie EHA, Mulder EEAP, Reijers S, Balduzzi S, Zuur CL, Klop WMC, van der Hiel B, Van de Wiel BA, Wouters MWJM, Schrage YM, van Houdt WJ, Grunhagen DJ, van Akkooi ACJ. PMID: 35569723 [PubMed - as supplied by publisher]
	Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study. Eur J Cancer Leyvraz S, Konietschke F, Peuker C, Schütte M, Kessler T, Ochsenreither S, Ditzhaus M, Sprünken ED, Dörpholz G, Lamping M, Rieke DT, Klinghammer K, Burock S, Ulrich C, Poch G, Schäfer R, Klauschen F, Joussen A, Yaspo ML, Keilholz U. PMID: 35569281 [PubMed - as supplied by publisher]
	Association between hypertension and cutaneous melanoma, and the effect of aspirin: extended follow-up of a large randomised controlled trial. Cancer Epidemiol Yan MK, Orchard SG, Adler NR, Wolfe R, McLean C, Rodríguez LM, Woods RL, Gibbs P, Chan AT, Haydon A, Mar VJ. PMID: 35567859 [PubMed - as supplied by publisher]
	The significance of intratumoural CD163⁺ macrophages in oral malignant melanoma: A preliminary study. Oral Dis Kodama T, Shigeoka M, Nishio M, Koma YI, Akashi M, Yokozaki H. PMID: 35567533 [PubMed - as supplied by publisher]
	Bis-Cinnamamide Derivatives as APE/Ref-1 Inhibitors for the Treatment of Human Melanoma. Molecules Alhazmi R, Tong S, Darwish S, Khanjani E, Khungar B, Chawla S, Zheng Z, Chamberlin R, Parang K, Yang S. PMID: 35566022 [PubMed - indexed for MEDLINE]
	Prognostic Value of IGF2 mRNA-Binding Protein 3 (IGF2BP3) Intratumoral Expression in Melanoma Patients at the Time of Diagnosis: Comparative Analysis of RT-qPCR Versus Immunohistochemistry. Cancers (Basel) Sánchez-Sendra B, Pérez-Debén S, González-Muñoz JF, Murgui A, Monteagudo C. PMID: 35565448 [PubMed]
	Potential Biomarkers of Skin Melanoma Resistance to Targeted Therapy-Present State and Perspectives. Cancers (Basel) Olbryt M. PMID: 35565444 [PubMed]
	Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma. Cancers (Basel) Homicsko K, Dummer R, Hoeller C, Wolchok JD, Hodi FS, Larkin J, Ascierto PA, Atkinson V, Robert C, Postow MA, Re S, Paulucci D, Dobler D, Michielin O. PMID: 35565428 [PubMed]
	The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma. Cancers (Basel) Janowska A, Iannone M, Fidanzi C, Romanelli M, Filippi L, Del Re M, Martins M, Dini V. PMID: 35565234 [PubMed]
	The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma-A Retrospective, Real-World Cohort Study. Cancers (Basel) Haist M, Stege H, Ebner R, Fleischer MI, Loquai C, Grabbe S. PMID: 35565212 [PubMed]
	The Lysosome in Malignant Melanoma: Biology, Function and Therapeutic Applications. Cells Hsu CH, Lee KJ, Chiu YH, Huang KC, Wang GS, Chen LP, Liao KW, Lin CS. PMID: 35563798 [PubMed - indexed for MEDLINE]
	Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment. Cells Maresca L, Stecca B, Carrassa L. PMID: 35563772 [PubMed - in process]

Artikel 1 - 20 / 121244

Seite 1 von 6063

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung